Saba Capital Amends Nuveen Real Asset Fund Stake

TL;DR

**Saba Capital just updated its Nuveen Real Asset Income & Growth Fund stake, signaling potential strategy shifts.**

AI Summary

Saba Capital Management, L.P. filed an amended Schedule 13D/A on January 18, 2024, indicating a change in their beneficial ownership of Nuveen Real Asset Income & Growth Fund (CUSIP 67074Y105) common shares. This amendment, dated January 16, 2024, updates their previous filing, signaling a potential shift in their investment strategy or level of influence over the fund. For investors, this matters because Saba Capital is an activist investor, and changes in their holdings or intentions can foreshadow future actions that might impact the fund's share price or governance.

Why It Matters

This filing signals an update to Saba Capital's position in Nuveen Real Asset Income & Growth Fund, which could indicate a change in their activist intentions or investment strategy, potentially influencing the fund's future direction or market perception.

Risk Assessment

Risk Level: medium — Changes in activist investor filings can introduce uncertainty or signal potential future corporate actions, which can lead to stock price volatility.

Analyst Insight

Investors should monitor subsequent filings from Saba Capital Management, L.P. regarding Nuveen Real Asset Income & Growth Fund for any disclosures of changes in their ownership percentage or stated intentions, as these could signal future activist campaigns or strategic shifts that may impact the fund's performance.

Key Numbers

• 67074Y105 — CUSIP Number (identifies the Common Shares of Nuveen Real Asset Income & Growth Fund)
• January 16, 2024 — Date of Event (the date triggering the requirement for this amendment filing)
• Amendment No. 4 — Amendment Number (indicates this is the fourth amendment to the original Schedule 13D filing)

Key Players & Entities

• Saba Capital Management, L.P. (company) — the reporting person filing the SC 13D/A
• Nuveen Real Asset Income & Growth Fund (company) — the subject company (issuer) of the securities
• Boaz R. Weinstein (person) — a group member associated with the filing
• Saba Capital Management GP, LLC (company) — a group member associated with the filing
• Michael D'Angelo (person) — person authorized to receive notices for Saba Capital Management, L.P.

Forward-Looking Statements

• Saba Capital Management, L.P. will continue to be an active shareholder in Nuveen Real Asset Income & Growth Fund. (Saba Capital Management, L.P.) — high confidence, target: 2025-01-18
• Further amendments to this Schedule 13D/A will be filed by Saba Capital Management, L.P. if their beneficial ownership or intentions significantly change. (Saba Capital Management, L.P.) — high confidence, target: 2024-12-31

FAQ

Key Financial Figures

• $0.01 — Fund (Name of Issuer) Common Shares, $0.01 par value (Title of Class of Securiti
• $28,002,150 — ported herein. A total of approximately $28,002,150 was paid to acquire the Common Shares r

Filing Documents

• formsc13da.htm (SC 13D/A) — 64KB
• exhibit3.htm (EX-3) — 14KB
• 0001062993-24-001011.txt ( ) — 79KB

is hereby amended and supplemented by the addition of the following

Item 6 is hereby amended and supplemented by the addition of the following: The Reporting Persons' response to Item 4 is incorporated by reference into this Item 6. Item 7. MATERIAL TO BE FILED AS EXHIBITS Exhibit 3 : Form of Nominee Agreement CUSIP No. 67074Y105 SCHEDULE 13D/A Page 7 of 8 Pages

SIGNATURES

SIGNATURES After reasonable inquiry and to the best of his or its knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct. Date: January 18, 2024 SABA CAPITAL MANAGEMENT, L.P. By: /s/ Michael D'Angelo Name: Michael D'Angelo Title: Chief Compliance Officer SABA CAPITAL MANAGEMENT GP, LLC By: /s/ Michael D'Angelo Name: Michael D'Angelo Title: Authorized Signatory BOAZ R. WEINSTEIN By: /s/ Michael D'Angelo Name: Michael D'Angelo Title: Attorney-in-fact* * Pursuant to a power of attorney dated as of November 16, 2015, which is incorporated herein by reference to Exhibit 2 to the Schedule 13G filed by the Reporting Persons on December 28, 2015, accession number: 0001062993-15-006823 CUSIP No. 67074Y105 SCHEDULE 13D/A Page 8 of 8 Pages Schedule A This Schedule sets forth information with respect to each purchase and sale of Common Shares which were effectuated by Saba Capital since the filing of the Schedule 13D/A on 12/5/23. All transactions were effectuated in the open market through a broker. Trade Date Buy/Sell Shares Price 12/5/2023 Buy 1,519 11.24 12/6/2023 Buy 7,884 11.33 12/12/2023 Buy 3,366 11.32 12/14/2023 Buy 22,368 11.85 1/2/2024 Buy 6,110 11.78 1/3/2024 Buy 22,971 11.87 1/4/2024 Buy 34,143 11.94 1/8/2024 Sell (38,623) 11.93 1/16/2024 Buy 12,657 11.69

View Full Filing

View this SC 13D/A filing on SEC EDGAR